BiopharmX vs Neothetics vs Galena
Seite 2 von 3 Neuester Beitrag: 24.04.21 23:13 | ||||
Eröffnet am: | 11.04.17 13:05 | von: Temesta | Anzahl Beiträge: | 57 |
Neuester Beitrag: | 24.04.21 23:13 | von: Lauranodya | Leser gesamt: | 28.866 |
Forum: | Hot-Stocks | Leser heute: | 5 | |
Bewertet mit: | ||||
Seite: < 1 | | 3 > |
„The special meeting of stockholders of Neothetics will be held on January 5, 2018 at 8:00 a.m., local time, at the offices of DLA Piper LLP (US) located at 4365 Executive Drive, Suite 1100, San Diego, CA 92121“
http://www.conferencecalltranscripts.org/no/summary2/?id=4400092
Denkt dran, wo der Kurs nach Closing stehen sollte: „Neothetics will issue and sell in a private placement transaction, or the Financing, $20 million of Neothetics common stock to existing Evofem Investors at a price per share equal to $2.0677“
http://www.conferencecalltranscripts.org/no/summary2/?id=4400092
Denkt dran, wo der Kurs nach Closing stehen sollte: „Neothetics will issue and sell in a private placement transaction, or the Financing, $20 million of Neothetics common stock to existing Evofem Investors at a price per share equal to $2.0677“
The ROTH Conference is basically a dick showing contest. 550 companies come from around the world and showcase their company and products. This should be great exposure for BPMX and if I am a betting man after the conference we will see higher volume and maybe a price jump.
2.) BPMX announces their earnings and possible FDA approval Date: March 22nd 2018
3.) Completion of BPX-01 and BPX-04, clinical trials Date: June 2018
- vorbörslich aktuell bei 0,61$ (-15%)
- geringe Cashreichweite
https://biopharmx.investorroom.com/...X-04-for-Papulopustular-Rosacea
https://biopharmx.investorroom.com/...-Quarter-2020-Financial-Results